Dynamic monitoring of EGFR mutations in circulating cell-free DNA for EGFR-mutant metastatic patients with lung cancer: Early detection of drug resistance and prognostic significance - Wikidata - awgldk - TriplyDB

Dynamic monitoring of EGFR mutations in circulating cell-free DNA for EGFR-mutant metastatic patients with lung cancer: Early detection of drug resistance and prognostic significance

Dynamic monitoring of EGFR mutations in circulating cell-free DNA for EGFR-mutant metastatic patients with lung cancer: Early detection of drug resistance and prognostic significance

http://www.wikidata.org/entity/Q33751216

about

A case report of EGFR mutant lung adenocarcinoma that acquired resistance to EGFR-tyrosine kinase inhibitors with T790M mutation and epithelial-to-mesenchymal transition.

P2860

Q41563298-CA1C9731-FD68-40CA-81C4-FC64B5C71268

P2860

Dynamic monitoring of EGFR mutations in circulating cell-free DNA for EGFR-mutant metastatic patients with lung cancer: Early detection of drug resistance and prognostic significance

http://www.wikidata.org/entity/Q33751216

description

2017 nî lūn-bûn

@nan

2017 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

Dynamic monitoring of EGFR mut ...... ce and prognostic significance

@ast

Dynamic monitoring of EGFR mut ...... ce and prognostic significance

@en

type

label

Dynamic monitoring of EGFR mut ...... ce and prognostic significance

@ast

Dynamic monitoring of EGFR mut ...... ce and prognostic significance

@en

prefLabel

Dynamic monitoring of EGFR mut ...... ce and prognostic significance

@ast

Dynamic monitoring of EGFR mut ...... ce and prognostic significance

@en

P1433

Q33751216-229EC989-2AF1-4DFE-B0B3-AB1C1DC4C101

P1476

Q33751216-CBB6D97E-747E-4209-9D38-2BAD8B5E6814

P2093

Q33751216-04953551-0F6D-480E-B9C3-06764B62A005

Q33751216-0824E014-2367-4982-9DDC-578EA032C598

Q33751216-27B9D1D4-5239-48A9-9F25-5034026E4317

Q33751216-838F85DF-06D8-4B49-88DE-5EFE806CF4AE

Q33751216-DD49EE65-AB7D-474C-A55F-049BAA8DA3CE

Q33751216-E4B9BD95-106F-432A-8208-108C03FA1EBF

P2860

Q33751216-004115AB-4B4A-4DDB-A2E6-0ED43DEF5CAC

Q33751216-08572235-BA8B-451C-8C7E-4BB05399CFD8

Q33751216-0960DF16-721F-41A4-8C58-06D2889BECC7

Q33751216-0B87116D-7A57-473E-9C8F-693D22754C33

Q33751216-1E402B08-215E-4593-8A4F-947FB7AB9CC8

Q33751216-3291CB70-FAB3-4A89-8219-BB499EA795D7

Q33751216-38361A17-F32F-438D-B414-3EEA5A9B552F

Q33751216-3971A90E-2501-4E93-A12A-ECE842C6BC43

Q33751216-3E7DA1B5-6014-490D-B581-3F742D7C42F8

Q33751216-426075D0-4BC0-4962-964F-D5D964172A51

P304

Q33751216-1AEDA847-B114-4EE4-9B40-B5B59E2B73CE

P31

Q33751216-4FE0D43D-38F5-44CF-813E-7B220E530A02

P356

Q33751216-9F6A42DA-FF54-4961-86B8-56E471E644E8

P433

Q33751216-8CDE2A5E-0C28-44BB-8FC7-35C7EB476883

P478

Q33751216-0E383A5A-4CE7-42BB-9F8A-47786E854CB0

P577

Q33751216-CCB01FA6-E36D-4D1A-8F8D-37D3C0381371

P698

Q33751216-F9017B85-F166-48A8-B0B2-145B2A5AF8A9

P932

Q33751216-D5E0BBCF-6D1F-44E2-91FE-656C5B762E07

P356

P1433

Oncology Letters

P1476

Dynamic monitoring of EGFR mut ...... ce and prognostic significance

@en

P2093

Chunmei Bai

http://www.w3.org/2001/XMLSchema#string

Jianjiao Ni

http://www.w3.org/2001/XMLSchema#string

Linqian Weng

http://www.w3.org/2001/XMLSchema#string

Yi Liu

http://www.w3.org/2001/XMLSchema#string

Yingyi Wang

http://www.w3.org/2001/XMLSchema#string

Zhao Sun

http://www.w3.org/2001/XMLSchema#string

P2860

EGFR mutation and resistance of non-small-cell lung cancer to gefitinib.

Analysis of tumor specimens at the time of acquired resistance to EGFR-TKI therapy in 155 patients with EGFR-mutant lung cancers.

AZD9291 in EGFR inhibitor-resistant non-small-cell lung cancer.

Rociletinib in EGFR-mutated non-small-cell lung cancer.

Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma

Blood-based analyses of cancer: circulating tumor cells and circulating tumor DNA

Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR

Detection of mutations in EGFR in circulating lung-cancer cells

Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial

Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA

P304

4549-4557

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OL.2017.6022

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

2017-04-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28599456

http://www.w3.org/2001/XMLSchema#string

P932

5453052

http://www.w3.org/2001/XMLSchema#string